Institut National de la Santé et de la Recherche Médicale, INSERM UMR-S 945 and Université Pierre et Marie Curie (UPMC University Paris 06), Laboratory of Immunity and Infection, 83/91, Boulevard de l'Hôpital, 75013 Paris Cedex 13, France.
Vaccine. 2011 Aug 26;29(37):6379-91. doi: 10.1016/j.vaccine.2011.04.080. Epub 2011 May 7.
Skin routes of immunization such as subcutaneous (SC), intradermal (ID) and transcutaneous (TC) administration are utilized for vaccination against various pathogens, without understanding their potential impact on the outcome of immune responses. We demonstrated that SC immunization induced HIV-1 p24 specific IgG in absence of antigen-specific CD8 T cells, whereas the ID route induced both cellular and humoral responses. Interestingly, TC application through empty hair follicular ducts, targeting epidermal Langerhans Cells (LCs), induced major CD8 effector cells, in the absence of IgG. However, high levels of mucosal IgA, were localized in the stratified epithelium of the vagina after TC prime. We propose that re-directing the immune responses by targeting differential skin immunization routes, offers enormous potential for innovative vaccination strategies, especially against HIV.
皮肤免疫途径,如皮下(SC)、皮内(ID)和经皮(TC)给药,被用于针对各种病原体的疫苗接种,而没有了解它们对免疫反应结果的潜在影响。我们证明,SC 免疫接种在没有抗原特异性 CD8 T 细胞的情况下诱导 HIV-1 p24 特异性 IgG,而 ID 途径诱导细胞和体液反应。有趣的是,通过空的毛囊管进行 TC 应用,靶向表皮朗格汉斯细胞(LCs),在没有 IgG 的情况下诱导主要的 CD8 效应细胞。然而,TC 引发后,大量的黏膜 IgA 定位于阴道的复层上皮中。我们提出,通过针对不同的皮肤免疫途径来重新引导免疫反应,为创新的疫苗接种策略提供了巨大的潜力,特别是针对 HIV。